Partners

Leveraging its unique, integrated drug discovery platform, Caraway has established a strategic collaboration with AbbVie to advance small molecule therapeutics directed against TMEM175 for the treatment of Parkinson’s disease and other neurodegenerative disorders.

Abbvie Ventures logo